The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes

By J. Wenzlau, Kirstine Juhl, Liping Yu, O. Moua, S. Sarkar, P. Gottlieb, M. Rewers, G. Eisenbarth, J. Jensen, H. Davidson and 1 more. Proceedings of the National Academy of Sciences of the United States of America, 2007

1,021 citations recorded by the source corpus.

Subfields: Genetics, Immunology, Surgery

View Paper: https://www.semanticscholar.org/paper/03fceb5d92feaf1a98da289e24740b473d0830ce

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

1. D. Nathan
2. M. S. Kirkman

In Surgery

1. G. Bakris
2. D. Nathan
3. M. S. Kirkman

Citations in the corpus

• Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association (2014, background): “Highly sensitive laboratory measurements capture ;98% of individuals with autoantibodies at diagnosis (10).”
• Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2002, background): “and IA-2bA (also known as phogrin) (291)], and to three variants of zinc transporter 8 (ZnT8A) (292,293).”
• Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2002, background): “and IA-2bA (also known as phogrin) (291)], and to three variants of zinc transporter 8 (ZnT8A) (292,293).”
• The Physiological, Biochemical, and Molecular Roles of Zinc Transporters in Zinc Homeostasis and Metabolism. (2015, background): “ZnT8 is also targeted by autoantibodies in 60–80% of new-onset type 1 diabetes (442).”